Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01300585 · ClinicalTrials.gov registry record · NA
MRI Evaluation of the Breast Areolar Margin and Paryenchyma
A NA study, sponsored by Piedmont Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01300585 is a NA study that was terminated before completion, run by Piedmont Healthcare. The registered enrollment target is 68 participants.
The verdict
NCT01300585, a NA study, was terminated before completion, sponsored by Piedmont Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new method of defining patterns of how breast glands are or are not attached to the overlying skin. All patients will have markers placed on both breasts and will undergo an MRI. MRI results will be examined to identify the pattern of breast gland attachment to the overlying skin. This will help identify patients which may benefit from areolar sparing and/or nipple sparing technique and which patients should be treated by standard mastectomy.
Interventions
- OTHER MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01300585
The ClinicalTrials.gov registry entry for NCT01300585 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Piedmont Healthcare, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01300585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01300585 about?
NCT01300585 is a clinical study titled "MRI Evaluation of the Breast Areolar Margin and Paryenchyma". The purpose of this study is to test a new method of defining patterns of how breast glands are or are not attached to the overlying skin. All patients will have markers placed on both breasts and will undergo an MRI. MRI results will be examined to identify the pattern of breast gland attachment to...
What is the current status of trial NCT01300585?
This trial is currently terminated. It is a NA study. The enrollment target is 68 participants. The study started on 2011-02. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01300585?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT01300585?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.